Revenue
$321.19M
Fiscal year ended 2026-06-30Operating income
$74.28M
Fiscal year ended 2026-06-30Free cash flow
$86.94M
Fiscal year ended 2026-06-30BIO-TECHNE Corp (TECH) reported revenue of $321.19M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BIO-TECHNE Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.19M | $311.42M | $295.88M | $286.56M | $316.96M | $316.18M | $297.03M | $289.46M | $306.10M | $303.43M |
| Cost of revenue | $109.80M | $103.13M | $104.60M | $98.44M | $118.15M | $101.62M | $103.14M | $106.44M | $102.75M | $98.83M |
| Gross profit | $211.39M | $208.29M | $191.28M | $188.11M | $198.81M | $214.56M | $193.89M | $183.02M | $203.35M | $204.60M |
| Operating income | $74.28M | $75.50M | $54.46M | $47.66M | -$23.86M | $38.71M | $47.42M | $39.99M | $45.82M | $67.00M |
| Net income | Unavailable | $51.05M | $38.01M | $38.18M | -$17.68M | $22.59M | $34.89M | $33.60M | $40.59M | $49.06M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | Unavailable | shares 157.40M | shares 157.00M | shares 156.36M | Unavailable | shares 158.94M | shares 160.63M | shares 161.12M | Unavailable | shares 160.50M |
| Pretax income | $70.68M | $71.22M | $50.78M | $47.99M | -$22.86M | $38.27M | $42.88M | $40.17M | $41.66M | $61.08M |
| Income tax expense | $16.06M | $20.18M | $12.78M | $9.81M | -$5.18M | $15.69M | $7.99M | $6.57M | $1.07M | $12.02M |
| Diluted EPS | Unavailable | $0.32 | $0.24 | $0.24 | Unavailable | $0.14 | $0.22 | $0.21 | Unavailable | $0.31 |
| Selling, general & administrative | $113.17M | $109.34M | $113.69M | $116.21M | $196.64M | $151.27M | $121.45M | $119.16M | $133.54M | $111.84M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $264.71M | $209.82M | $172.88M | $144.96M | $162.19M | $140.67M | $177.55M | $187.54M | $151.79M | $139.92M |
| Total assets | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B |
| Current assets | $744.40M | $688.05M | $637.43M | $609.51M | $608.30M | $627.24M | $634.64M | $648.57M | $617.42M | $610.65M |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $163.70M | $153.28M | $140.43M | $144.54M | $175.85M | $169.20M | $161.26M | $142.13M | $159.38M | $149.82M |
| Total equity incl. NCI | $2.11B | $2.09B | $2.01B | $1.97B | $1.92B | $2.02B | $2.08B | $2.14B | $2.07B | $2.01B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $195.74M | $201.18M | $205.45M | $203.19M | $189.45M | $191.08M | $188.37M | $185.04M | $179.73M | $179.50M |
| Accounts receivable | $216.58M | $214.56M | $184.61M | $183.90M | $206.88M | $237.14M | $217.94M | $223.69M | $241.39M | $227.89M |
| Goodwill | $975.36M | $977.80M | $980.56M | $978.91M | $980.94M | $968.61M | $964.61M | $982.58M | $972.66M | $970.97M |
| Long-term debt | $200.00M | $200.00M | $260.00M | $300.00M | $346.00M | $330.00M | $300.00M | $300.00M | $319.00M | $389.00M |
| Accounts payable | $26.70M | $23.49M | $26.27M | $30.16M | $25.31M | $31.64M | $33.12M | $31.56M | $37.97M | $28.90M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $95.42M | $86.66M | $82.41M | $27.58M | $98.20M | $41.12M | $84.35M | $63.89M | $75.50M | $80.99M |
| Capital expenditures | $8.48M | $9.09M | $5.92M | $5.36M | $4.89M | $10.12M | $6.82M | $9.17M | $17.98M | $16.44M |
| Investing cash flow | -$7.06M | -$5.82M | -$5.92M | $605.00K | $406.00K | -$8.87M | -$5.03M | -$21.68M | -$8.81M | -$16.44M |
| Financing cash flow | -$33.21M | -$42.72M | -$48.99M | -$44.20M | -$90.45M | -$68.04M | -$83.84M | -$11.57M | -$60.10M | -$52.42M |
| Net change in cash | $54.89M | $36.94M | $27.92M | -$17.22M | $21.52M | -$36.88M | -$9.99M | $35.75M | $11.88M | $9.78M |
| Stock-based compensation | $5.23M | $10.50M | $13.96M | $11.68M | $4.55M | $11.39M | $14.71M | $10.18M | $7.06M | $8.13M |
| Common dividends paid | $12.48M | $12.52M | $12.47M | $12.44M | $12.39M | $12.58M | $12.74M | $12.69M | $12.63M | $12.58M |
| Common share repurchases | $41.65M | $0 | $0 | $24.00K | $100.06M | $100.05M | Unavailable | Unavailable | $0 | $0 |
| Depreciation & amortization | $24.14M | $24.17M | $24.71M | $24.34M | $27.11M | $27.57M | $27.08M | $28.14M | $28.06M | $27.31M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $86.94M | $77.58M | $76.49M | $22.22M | $93.31M | $31.00M | $77.52M | $54.72M | $57.52M | $64.54M |
| Gross margin | 65.8% | 66.9% | 64.6% | 65.6% | 62.7% | 67.9% | 65.3% | 63.2% | 66.4% | 67.4% |
| Operating margin | 23.1% | 24.2% | 18.4% | 16.6% | -7.5% | 12.2% | 16.0% | 13.8% | 15.0% | 22.1% |
| FCF margin | 27.1% | 24.9% | 25.9% | 7.8% | 29.4% | 9.8% | 26.1% | 18.9% | 18.8% | 21.3% |
| SBC / revenue | 1.6% | 3.4% | 4.7% | 4.1% | 1.4% | 3.6% | 5.0% | 3.5% | 2.3% | 2.7% |
| Current ratio | 4.55x | 4.49x | 4.54x | 4.22x | 3.46x | 3.71x | 3.94x | 4.56x | 3.87x | 4.08x |
| Revenue YoY growth | 1.3% | -1.5% | -0.4% | -1.0% | 3.5% | 4.2% | 9.0% | 4.5% | 1.6% | 3.2% |
| Net margin | Unavailable | 16.4% | 12.8% | 13.3% | Unavailable | 7.1% | 11.7% | 11.6% | Unavailable | 16.2% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 2.6% | 2.9% | 2.0% | 1.9% | 1.5% | 3.2% | 2.3% | 3.2% | 5.9% | 5.4% |
| Long-term debt / equity | 0.09x | 0.10x | Unavailable | Unavailable | 0.18x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 22.7% | 28.3% | 25.2% | 20.4% | Unavailable | 41.0% | 18.6% | 16.4% | 2.6% | 19.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TECH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-K · Filed 2026-08-24View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-K · Filed 2025-08-22View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.